GENTIAN DIAGNOSTICS ASA (GENT.OL) Stock Fundamental Analysis
OSL:GENT - Euronext Oslo - NO0010748866 - Common Stock - Currency: NOK
Taking everything into account, GENT scores 6 out of 10 in our fundamental rating. GENT was compared to 53 industry peers in the Health Care Equipment & Supplies industry. GENT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. GENT is growing strongly while it is still valued neutral. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year GENT was profitable.
In the past year GENT had a positive cash flow from operations.
In the past 5 years GENT reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: GENT reported negative operating cash flow in multiple years.
1.2 Ratios
GENT has a better Return On Assets (19.72%) than 96.23% of its industry peers.
Looking at the Return On Equity, with a value of 23.34%, GENT belongs to the top of the industry, outperforming 88.68% of the companies in the same industry.
With a decent Return On Invested Capital value of 6.07%, GENT is doing good in the industry, outperforming 66.04% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 19.72% | ||
| ROE | 23.34% | ||
| ROIC | 6.07% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 29.78%, GENT belongs to the top of the industry, outperforming 96.23% of the companies in the same industry.
GENT has a better Operating Margin (10.34%) than 62.26% of its industry peers.
GENT's Gross Margin of 54.46% is in line compared to the rest of the industry. GENT outperforms 49.06% of its industry peers.
GENT's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.34% | ||
| PM (TTM) | 29.78% | ||
| GM | 54.46% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GENT is destroying value.
GENT has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for GENT remains at a similar level compared to 5 years ago.
The debt/assets ratio for GENT has been reduced compared to a year ago.
2.2 Solvency
GENT has an Altman-Z score of 12.96. This indicates that GENT is financially healthy and has little risk of bankruptcy at the moment.
GENT has a Altman-Z score of 12.96. This is amongst the best in the industry. GENT outperforms 100.00% of its industry peers.
GENT has a debt to FCF ratio of 2.20. This is a good value and a sign of high solvency as GENT would need 2.20 years to pay back of all of its debts.
GENT has a better Debt to FCF ratio (2.20) than 84.91% of its industry peers.
GENT has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
GENT has a better Debt to Equity ratio (0.03) than 94.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 2.2 | ||
| Altman-Z | 12.96 |
ROIC/WACC0.71
WACC8.59%
2.3 Liquidity
A Current Ratio of 5.38 indicates that GENT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.38, GENT belongs to the top of the industry, outperforming 98.11% of the companies in the same industry.
GENT has a Quick Ratio of 3.85. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
GENT has a better Quick ratio (3.85) than 90.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.38 | ||
| Quick Ratio | 3.85 |
3. Growth
3.1 Past
GENT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 522.84%, which is quite impressive.
Looking at the last year, GENT shows a quite strong growth in Revenue. The Revenue has grown by 12.52% in the last year.
Measured over the past years, GENT shows a very strong growth in Revenue. The Revenue has been growing by 25.96% on average per year.
EPS 1Y (TTM)522.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%422.94%
Revenue 1Y (TTM)12.52%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%13.73%
3.2 Future
Based on estimates for the next years, GENT will show a very strong growth in Earnings Per Share. The EPS will grow by 58.89% on average per year.
The Revenue is expected to grow by 31.47% on average over the next years. This is a very strong growth
EPS Next Y76.24%
EPS Next 2Y58.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year33.11%
Revenue Next 2Y31.47%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 17.13, GENT is valued on the expensive side.
GENT's Price/Earnings ratio is rather cheap when compared to the industry. GENT is cheaper than 81.13% of the companies in the same industry.
GENT's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.79.
Based on the Price/Forward Earnings ratio of 27.26, the valuation of GENT can be described as expensive.
GENT's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of GENT to the average of the S&P500 Index (21.38), we can say GENT is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.13 | ||
| Fwd PE | 27.26 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as GENT.
GENT's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 304.46 | ||
| EV/EBITDA | 25.96 |
4.3 Compensation for Growth
GENT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GENT's earnings are expected to grow with 58.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y58.89%
EPS Next 3YN/A
5. Dividend
5.1 Amount
GENT has a yearly dividend return of 0.85%, which is pretty low.
Compared to an average industry Dividend Yield of 2.45, GENT pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.85, GENT pays less dividend than the S&P500 average, which is at 2.51.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.85% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y58.89%
EPS Next 3YN/A
OSL:GENT (4/25/2025, 7:00:00 PM)
49.5
-0.5 (-1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners30.99%
Inst Owner ChangeN/A
Ins Owners2.59%
Ins Owner ChangeN/A
Market Cap763.29M
Analysts85.71
Price Target68.34 (38.06%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.85% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)9.88%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.13 | ||
| Fwd PE | 27.26 | ||
| P/S | 5.02 | ||
| P/FCF | 304.46 | ||
| P/OCF | 56.72 | ||
| P/B | 3.93 | ||
| P/tB | 4.61 | ||
| EV/EBITDA | 25.96 |
EPS(TTM)2.89
EY5.84%
EPS(NY)1.82
Fwd EY3.67%
FCF(TTM)0.16
FCFY0.33%
OCF(TTM)0.87
OCFY1.76%
SpS9.86
BVpS12.58
TBVpS10.74
PEG (NY)0.22
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 19.72% | ||
| ROE | 23.34% | ||
| ROCE | 7.88% | ||
| ROIC | 6.07% | ||
| ROICexc | 10.54% | ||
| ROICexgc | 14.02% | ||
| OM | 10.34% | ||
| PM (TTM) | 29.78% | ||
| GM | 54.46% | ||
| FCFM | 1.65% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
F-Score5
Asset Turnover0.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 2.2 | ||
| Debt/EBITDA | 0.22 | ||
| Cap/Depr | 122.17% | ||
| Cap/Sales | 7.2% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 54.51% | ||
| Profit Quality | 5.54% | ||
| Current Ratio | 5.38 | ||
| Quick Ratio | 3.85 | ||
| Altman-Z | 12.96 |
F-Score5
WACC8.59%
ROIC/WACC0.71
Cap/Depr(3y)104.09%
Cap/Depr(5y)116.83%
Cap/Sales(3y)8.32%
Cap/Sales(5y)10.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)522.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%422.94%
EPS Next Y76.24%
EPS Next 2Y58.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.52%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%13.73%
Revenue Next Year33.11%
Revenue Next 2Y31.47%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y318.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year184.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-77.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.94%
OCF growth 3YN/A
OCF growth 5YN/A